Global Freezing of Gait Treatment Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Freezing of Gait Treatment Market Research Report 2024
Freezing of gait, or FOG, is said to affect approximately 7% of individuals with early Parkinson’s disease (PD) and more than half of those with advanced PD.1This is due to the loss of postural reflexes, which are automatic movements that help us maintain equilibrium and balance when we are standing upright. FOG is usually defined as an onset of not being able to start stepping forward, with no apparent cause, and can be exacerbated by stress or distraction.1 FOG can look like trembling of the legs, shortening of steps or shuffling, or feeling like one is unable to move their feet.2 It’s one of the most debilitating aspects of PD and can increase fall risk. While there is no known cure for this, there are potential treatments for it, and ways to prevent FOG are being explored.
According to MRAResearch’s new survey, global Freezing of Gait Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Freezing of Gait Treatment market research.
Key companies engaged in the Freezing of Gait Treatment industry include Acorda Therapeutics, The Michael J. Fox Foundation, GYENNO, MedEXO Robotics and TABLE Teva Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Freezing of Gait Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Freezing of Gait Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Freezing of Gait Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Acorda Therapeutics
The Michael J. Fox Foundation
GYENNO
MedEXO Robotics
TABLE Teva Pharmaceuticals
Segment by Type
Oral Dopaminergic Medication
Wearable and Walking Aid Devices
Deep Brain Stimulation
Others
Hospitals
Clinics
Research and Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Freezing of Gait Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Freezing of Gait Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Freezing of Gait Treatment market research.
Key companies engaged in the Freezing of Gait Treatment industry include Acorda Therapeutics, The Michael J. Fox Foundation, GYENNO, MedEXO Robotics and TABLE Teva Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Freezing of Gait Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Freezing of Gait Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Freezing of Gait Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Acorda Therapeutics
The Michael J. Fox Foundation
GYENNO
MedEXO Robotics
TABLE Teva Pharmaceuticals
Segment by Type
Oral Dopaminergic Medication
Wearable and Walking Aid Devices
Deep Brain Stimulation
Others
Segment by Application
Hospitals
Clinics
Research and Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Freezing of Gait Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source